<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shen Z</submitter><funding>CAMS Innovation Fund for Medical Sciences</funding><funding>National Natural Science Foundation of China</funding><funding>the Fundamental Research Funds for the Central public welfare research institutes</funding><pagination>803</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11273404</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(7)</volume><pubmed_abstract>Pregabalin is a medication primarily used in the treatment of neuropathic pain and anxiety disorders, owing to its gabapentinoid properties. Pregabalin monotherapy faces limitations due to its variable efficacy and dose-dependent adverse reactions. In this study, we conducted a comprehensive investigation into the potentiation of pregabalin's analgesic effects by dexborneol, a neuroprotective bicyclic monoterpenoid compound. We performed animal experiments where pain models were induced using two methods: peripheral nerve injury, involving axotomy and ligation of the tibial and common peroneal nerves, and incisional pain through a longitudinal incision in the hind paw, while employing a multifaceted methodology that integrates behavioral pharmacology, molecular biology, neuromorphology, an</pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Dexborneol Amplifies Pregabalin's Analgesic Effect in Mouse Models of Peripheral Nerve Injury and Incisional Pain.</pubmed_title><pmcid>PMC11273404</pmcid><funding_grant_id>ZZ-JQ2023008</funding_grant_id><funding_grant_id>2022-I2M-1-016</funding_grant_id><funding_grant_id>82374061</funding_grant_id><pubmed_authors>Guo YD</pubmed_authors><pubmed_authors>Tie C</pubmed_authors><pubmed_authors>Zhou P</pubmed_authors><pubmed_authors>Tang MZ</pubmed_authors><pubmed_authors>Han YX</pubmed_authors><pubmed_authors>Shen HR</pubmed_authors><pubmed_authors>Gao TL</pubmed_authors><pubmed_authors>Shen Z</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Jiang W</pubmed_authors><pubmed_authors>Jiang JD</pubmed_authors><pubmed_authors>Su YX</pubmed_authors><pubmed_authors>Cui JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dexborneol Amplifies Pregabalin's Analgesic Effect in Mouse Models of Peripheral Nerve Injury and Incisional Pain.</name><description>Pregabalin is a medication primarily used in the treatment of neuropathic pain and anxiety disorders, owing to its gabapentinoid properties. Pregabalin monotherapy faces limitations due to its variable efficacy and dose-dependent adverse reactions. In this study, we conducted a comprehensive investigation into the potentiation of pregabalin's analgesic effects by dexborneol, a neuroprotective bicyclic monoterpenoid compound. We performed animal experiments where pain models were induced using two methods: peripheral nerve injury, involving axotomy and ligation of the tibial and common peroneal nerves, and incisional pain through a longitudinal incision in the hind paw, while employing a multifaceted methodology that integrates behavioral pharmacology, molecular biology, neuromorphology, an</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-07-09T11:17:06.834Z</modification><creation>2026-07-09T10:43:55.861Z</creation></dates><accession>S-EPMC11273404</accession><cross_references><pubmed>39061872</pubmed><doi>10.3390/antiox13070803</doi></cross_references></HashMap>